Definitive Healthcare Special Committee Confirms Advent's $1.02/Share Going-Private Proposal
DH sits 69% above its 52-week low of $0.61.
Summary
Advent International has proposed to take Definitive Healthcare private at $1.02 per share in cash, with the independent Special Committee now formally reviewing the offer.
Key Events · M&A and Partnerships · DH
-
Going-Private Proposal Received
Advent International proposed to acquire all outstanding Class A shares and Definitive OpCo Units not already owned by Advent or Jason Krantz for $1.02 per share in cash.
-
Special Committee Formed
The Special Committee, composed entirely of disinterested and independent directors, will review the proposal with Rothschild & Co as financial advisor and Skadden Arps as legal counsel.
-
Founder Rollover Consideration
Founder Jason Krantz holds 17.6% of Class A shares and is weighing a full equity rollover into the surviving company, though his participation remains non-binding.
-
Delisting Deadline Looms
The company faces a Nasdaq minimum bid price delisting deadline of December 15, 2026, adding urgency to the strategic review.
Analysis · DH · Technology
Advent International, which already controls 58.54% of Definitive Healthcare, has formally proposed to acquire all remaining shares at $1.02 per share in cash. The Special Committee — composed entirely of independent directors — will evaluate the offer with Rothschild & Co and Skadden Arps advising. This is a thesis-altering event for minority shareholders: the offer price sits just below today's $1.03 trading level, and the company faces a Nasdaq delisting deadline of December 15, 2026, alongside a 9% YoY revenue decline. Founder Jason Krantz's 17.6% stake and potential rollover into the surviving entity adds complexity to the negotiation dynamics.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.2% of the 374 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DH was trading at $1.03 on NASDAQ in the Technology sector, with a market capitalization of approximately $130.7M. The 52-week trading range was $0.61 to $4.35. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.